language_icon
EN
HI

Kilitch Drugs (India) Share price

KILITCH

153.67

1.40 (-0.90%)
NSE
BSE
Last updated on 15 May, 2026 | 15:31 IST
Today's High

156.24

Today's Low

150.96

52 Week Low

117.25

52 Week High

250.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Kilitch Drugs (India) Chart

Kilitch Drugs (India) Share Key Metrics

Volume
20329.00
Market Cap
537.25 CR
LTQ@LTP
10@153.67
ATP
153.59
Var Margin
21.14 %
Circuit Range
124.06-186.08
Delivery %
32.71 %
Value
31.22 L
ASM/GSM
No
Market Lot
1

Summary

Kilitch Drugs (India) share price is ₹153.67 as of 17 May, 2026. The stock Kilitch Drugs (India) intraday movement has stayed between ₹150.96 and ₹156.24, while on a 52-week basis,Kilitch Drugs (India) price 52 week high is ₹250.00 & its 52 week low is ₹117.25.
In terms of trading activity, Kilitch Drugs (India) has recorded a volume of 20329 shares, The Kilitch Drugs (India) has a market cap of ₹34961564 CR. The stock’s Average Traded Price (ATP) stands at ₹153.59, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹153.67.
Kilitch Drugs (India) operates within a circuit range of ₹124.06 – ₹186.08, with a Value of ₹31.22 L. The Delivery Percentage for the day is 32.71%. Additionally, Kilitch Drugs (India) currently falls under the No framework, and trades with a market lot size of 1.

Kilitch Drugs (India) Fundamentals

View More
P/E Ratio

20.54

P/B Ratio

1.86

Div. Yield

0

Sector P/E

71.32

Sector P/B

3.47

Sec. Div. Yield

0.56

Kilitch Drugs (India) Resistance and Support

Pivot 156.34

Resistance

First Resistance

159.68

Second Resistance

164.29

Third Resistance

167.63

Support

First Support

151.73

Second Support

148.39

Third Support

143.78

Kilitch Drugs (India) Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

63.77%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

36.22%

Others

0.01%

Total Promoters
MAR '26
63.77%

Kilitch Drugs (India) Corporate Actions

DateAgenda
2026-05-15Audited Results
2026-02-11Quarterly Results & Bonus issue
2025-11-13Quarterly Results
2025-05-19Audited Results
2025-02-11Quarterly Results

Kilitch Drugs (India) News

Kilitch Drugs India Ltd - 524500 - Board Meeting Outcome for Submission Of Audited Standalone And Consolidated Financial Results For The Quarter Ended 31St March, 2026

Kilitch Drugs' board approved Q4 FY26 audited standalone revenue of ₹71.97 cr (up 27.8% YoY) and net profit of ₹14.00 cr (up 23.1% YoY). Consolidated revenue rose 46.3% to ₹89.60 cr and net profit increased 45.6% to ₹14.88 cr for the quarter. The company also issued 1:1 bonus shares on March 25, 2026.
May 15 2026 19:05:00

Kilitch Drugs India Ltd - 524500 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Kilitch Drugs (India) Ltd. reported that ₹1.12 crore from its Rights Issue proceeds, earmarked for capital expenditure, remains unutilized. The deployment, originally scheduled by March 31, 2026, is now expected by Q1FY27 due to a pending final inspection of the greenfield project.
May 15 2026 18:05:00

Kilitch Drugs (India) Limited

KILITCH DRUGS board to meet on May 15, 2026, for Q4 & FY26 results. The meeting will review audited standalone and consolidated financials.
May 07 2026 11:05:00

Kilitch Drugs (India) Limited

Kilitch Drugs (India) Limited announced a board meeting on May 15, 2026. The agenda includes considering and approving the audited standalone and consolidated financial results for the fourth quarter of FY26.
May 07 2026 11:05:00

Kilitch Drugs (India) Limited

Kilitch Drugs (India) Limited announced a board meeting on May 15, 2026. The agenda includes considering and approving the audited standalone and consolidated financial results for the fourth quarter of FY26.
May 07 2026 11:05:00

Kilitch Drugs (India) Limited

Kilitch Drugs (India) Limited announced that its Board of Directors will convene on May 15, 2026. The primary agenda is to consider and approve the audited financial results for the fourth quarter and full financial year ended March 31, 2026.
May 07 2026 11:05:00

Kilitch Drugs India Ltd - 524500 - Board Meeting Intimation for Considering And Approval Of The Audited Financial Results For The Quarter And Year Ended 31St March 2026

Kilitch Drugs' board will convene on May 15, 2026, to approve the company's audited financial results for Q4 FY26 and the full fiscal year ended March 31, 2026.
May 07 2026 11:05:00
Read More

About Kilitch Drugs (India)

NSE : 19937  
BSE : 524500  
ISIN : INE729D01010  

M/s Kilitch Drugs (India) ltd was incorporated on 12th May 1992 with the Registrar of Companies Maharashtra at Bombay as a public limited company and obtained certificate for commencement of business dated 26-05-92. The company went Public in February 1994 for setting up a pharmaceutical formulation plant to manufacture pharmaceutical products in the form of tablets capsules liquid orals ointments creams and injectables. The company could not commence its manufacturing activities as planned in the Public Issue on account of delay in completion of building. Till date the company has not commenced any manufacturing activities. The land and building is now completed and in order to have the benefit of its capacity the company is planning thisrights issue for expanding its injectable capacity from 30000 ltrs. to 75000 Itrs.PRESENT BUSINESSDue to delay in implementation of project the company could not come out with its own production till date and therefore the company is presently trading in pharmaceutical formulations like tablets capsules liquid orals ointments creams and injectables. The tradingturnover of the company for the year 1994-95 was Rs.550.50 Lacs.

Read More

Kilitch Drugs (India) Management

NamePosition
Pushpa NyoupaneCompany Secretary & Compliance Officer
Mukund P MehtaManaging Director
View More

Kilitch Drugs (India) FAQs

The Buying Price of Kilitch Drugs (India) share is 153.67 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Kilitch Drugs (India) stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Kilitch Drugs (India), choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Kilitch Drugs (India) shares is 20.54. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Kilitch Drugs (India) shares is 1.86. Useful to assess the stock's value relative to its book value.

To assess Kilitch Drugs (India)’s valuation compare Sector P/E, P/B which are 71.32 & 3.47 with sector averages, along with growth rates and financial metrics.

The Market Cap of Kilitch Drugs (India) is 537.25 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Kilitch Drugs (India) share price is 250.00 & 117.25. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Kilitch Drugs (India) belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost